Indicaton

A. baumannii

Debio 1454 is a FabI inhibitor targeting a combination of enteric bacteria species, A. baumannii, Enterobacter Spp., Klebsiella pneumoniae and E.coli. This compound belongs to a family of narrow-spectrum antiobiotics that combines a very potent activity on pathogens of interest while reducing the selective pressure on other bacterial strains and sparing the microbiome.

Therapeutic indications
Type of product
Table
  • Phase

    Discovery

  • Partnering status

    Not partnered

You may also be interested in